
The main purpose of this webinar is to present some novel advances in the use of silver-based materials for therapy. Silver nanoparticles have gained significant attention in the field of biomedicine, primarily for their antimicrobial properties. However, these versatile nanoparticles are now emerging as multifaceted therapeutic agents capable of being used to address a wide range of diseases. AgNPs exhibit size- and shape-dependent properties, allowing them to be tailored for specific applications.
This webinar will include presentations from Dr. Goreti Pereira (University of Aveiro, Portugal), Dr. Jermy Rabindran (Imam Abdulrahman Bin Faisal University, Kingdom of Saudi Arabia), and Dr. Debbie Crans (Colorado State University, United States of America).
Date: 4 February, 2026
Time: 16:00 WET | 11:00 EST
Webinar ID: 851 1492 2063
Webinar Secretariat: journal.webinar@mdpi.com
The 6th Pharmaceuticals webinar provided an overview of key advancements in pharmaceutical sciences, with a spotlight on silver-based nanoparticles for cancer therapy, diabetes management, and phototherapy. It featured discussions on nanoparticle design strategies to tackle contemporary therapeutic challenges. This event counted on the collaboration of Dr. Rabindran Jermy, Dr. Debbie C. Crans, and Dr. Pereira, fostering interactive discussions, knowledge exchange, and networking opportunities.
The webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe” at the top of the page.
"Therapeutic Potential of Silver Nanoparticles (AgNPs), 2nd Edition"
Edited by Dr. Goreti Pereira
"Therapeutic Potential of Silver Nanoparticles (AgNPs)"
Edited by Dr. Goreti Pereira
Deadline for manuscript submissions: Closed (30 November 2024)
"Metal-Based Nanoparticles’ Biological Activity and Pharmaceutical Applications, 2nd Edition"
Edited by Dr. Elitsa L. Pavlova and Prof. Dr. Debbie C. Crans
Deadine for manuscript submissions: 25 March 2026